Revenla Tablet, Film Coated
NDC Package 87367-166-12

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Revenla (sevelamer carbonate) tablets is sevelamer is used to lower high blood phosphorus (phosphate) levels in patients who are on dialysis due to severe kidney disease. This formulation utilizes a tablet, film coated delivery system. Marketed by Insignamedex Llc, this product is identified by NDC 87367-166 and is authorized under FDA application ANDA212970.

Identification & Billing

NDC Package Code
87367-166-12
Package Description
800 mg in 1 BOTTLE
Product Code
87367-166
11-Digit Billing Format
87367016612

Clinical Specifications

Proprietary Name
Revenla
Non-Proprietary Name
Sevelamer Carbonate
Substance Name
Sevelamer Carbonate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SEVELAMER CARBONATE 800 mg/800mg
Pharmacologic Class
Usage Information
Sevelamer is used to lower high blood phosphorus (phosphate) levels in patients who are on dialysis due to severe kidney disease. Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and possibly decrease the risk of heart disease and strokes that can result from high phosphate levels. Sevelamer works by holding onto phosphate from the diet so that it can pass out of your body.

Regulatory & Marketing

Labeler Name
Insignamedex Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA212970
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-19-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87367-166-12 identifies a specific commercial package of 800 mg in 1 bottle of Revenla, a human prescription drug labeled by Insignamedex Llc. This tablet, film coated is formulated for oral use and contains sevelamer carbonate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Insignamedex Llc on June 19, 2026.

What are the primary indications for this medication?

Sevelamer is used to lower high blood phosphorus (phosphate) levels in patients who are on dialysis due to severe kidney disease. Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and possibly decrease the risk of heart disease and strokes that can result from high phosphate levels. Sevelamer works by holding onto phosphate from the diet so that it can pass out of your body.

How is this Insignamedex Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87367016612. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87367-166-12
11-Digit CMS (5-4-2)
87367-0166-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.